| 27.09. | European ADRs Move Higher in Monday Trading |  |
| 27.09. | ASTRAZENECA : des résultats à venir dans la Covid-19 |  |
| 27.09. | ASTRAZENECA : Biohaven's neurological disorder drug candidate fails study | |
| 27.09. | ASTRAZENECA : EU Commission proposes extending vaccine export-control scheme | |
| 27.09. | SHIELD THERAPEUTICS : Names New Chief Medical Officer | |
| 27.09. | ASTRAZENECA : EU Commission proposes extending vaccine export-control scheme | |
| 27.09. | ASTRAZENECA : Small study shows antibody growth from AstraZeneca, Sputnik Light COVID-19 v.. | |
| 27.09. | ASTRAZENECA : Pfizer Deny Spat Following Lawyer's Leaked Health Threat Accusation | |
| 27.09. | ASTRAZENECA : COVID-19 and RSV presentations at IDWeek 2021 will showcase scientific progr.. | |
| 27.09. | ASTRAZENECA : Pfizer's comments on rival vaccine posed 'health threat' | |
| 27.09. | Global vaccines project to revamp rules after Britain got more than Botswana | |
| 27.09. | ASTRAZENECA PHARMA INDIA : Gets Import Nod for Selumetinib | |
| 26.09. | CORONAVIRUS : le point sur la pandémie dans le monde | |
| 24.09. | COVID : boost d'anticorps avec une 3e dose Pfizer, après deux doses de Coronavac | |
| 24.09. | Acciones europeas caen por temores sobre Evergrande, débil confianza empresarial aleman.. |  |
| 24.09. | Health Care Stocks Retreat Friday | |
| 24.09. | Eurostoxx 50 : European stocks slip on Evergrande woes, weak German business morale | |
| 24.09. | European ADRs Move Lower in Friday Trading | |
| 24.09. | Wall Street Tumbles Pre-Bell, Evergrande Risks Resurface | |
| 24.09. | Health Care Stocks Slip Pre-Bell Friday | |
| 24.09. | IMPERIAL COLLEGE LONDON : Imperial RNA technology to be developed by VaxEquity with AstraZ.. | |
| 24.09. | MERCK : résultats encourageants dans le cancer de la prostate | |
| 24.09. | DEPARTMENT OF HEALTH AND SOCIAL CARE : check the rules for travel to England from abroad | |
| 24.09. | ASTRAZENECA : Lynparza in combination with abiraterone significantly delayed disease progr.. | |
| 24.09. | ASTRAZENECA : LYNPARZA® (olaparib) in combination with abiraterone significantly delayed d.. | |
| 24.09. | EUROPEAN MIDDAY BRIEFING : Stocks Fall as Evergrande Payment Deadline Passes | |
| 24.09. | ASTRAZENECA : Lynparza in combination with abiraterone significantly delayed disease progr.. | |
| 24.09. | Astrazeneca plc Announces Positive High-Level Results from the Propel Phase III Trial A.. | |
| 24.09. | London Stocks Fall as Investors Turn Cautious; Oil Stocks Rise | |
| 24.09. | Les Bourses en léger repli, Evergrande au centre des préoccupations | |
| 24.09. | ASTRAZENECA : Merck & Co.'s Combination Therapy Benefits Prostate Cancer Patients in Phase.. | |
| 24.09. | BÖRSE LONDON : Nervousness rises | |
| 24.09. | European stocks slip on Evergrande woes, weak German business morale | |
| 24.09. | EUROPA : Las bolsas europeas caen al resurgir la preocupación por Evergrande | |
| 24.09. | FTSE 100 slips as slowdown worries, inflation fears persist | |
| 24.09. | ASTRAZENECA : résultats positifs dans le cancer de la prostate | |
| 24.09. | ASTRAZENECA : Vietnam cuts gap between AstraZeneca vaccine shots in largest city | |
| 24.09. | ADHERIUM : to Supply Hailie Solution to AstraZeneca | |
| 24.09. | ASTRAZENECA : Merck & Co.'s Prostate Cancer Drug Extends Lives in Late-Stage Study | |
| 24.09. | AstraZeneca's Prostate-Cancer Propel Phase 3 Trial Met Primary Point | |
| 24.09. | ASTRAZENECA : Australia hits vaccine milestone as Melbourne cases hover near record levels | |
| 23.09. | CORONAVIRUS : l'AEM doit se prononcer sur la troisième dose début octobre | |
| 23.09. | ASTRAZENECA : la pharma se lance dans l'ARN messager avec VaxEquity | |
| 23.09. | ASTRAZENECA : Vaccination Against Covid-19 Resumes Sept 24 | |
| 23.09. | COVID : Ema, continuiamo a raccomandare 2 dosi vaccino AstraZeneca |  |
| 23.09. | VC DAILY : Biotechs Seek New Skill Set From -2- | |
| 23.09. | Redhill Biopharma, AstraZeneca, Nektar Therapeutics Settle Movantik Patent Litigation w.. | |
| 23.09. | BÖRSE WALL STREET : As smooth as silk | |
| 23.09. | ASTRAZENECA : A Sense of Comfort, Providing Housing to Patients and their Families During .. | |
| 23.09. | ASTRAZENECA : Science Committee appointment (Form 6-K) | |
| 23.09. | ASTRAZENECA : establishes new Sustainability Committee of the Board (Form 6-K) | |
| 23.09. | ANALYST RECOMMENDATIONS : Amgen, Apple, AstraZeneca, FedEx, T-Mobile US... | |
| 23.09. | PLANÈTE BOURSE : La revue de presse du jeudi 23 septembre 2021 | |
| 23.09. | ASTRAZENECA : Coronavirus - 40,000 Vaccines Administered in Private Pharmacies | |
| 23.09. | ASTRAZENECA : Covid to be like the common cold - one day, says vaccine co-designer | |
| 23.09. | ASTRAZENECA : développe l'ARN auto-amplifié avec VaxEquity | |
| 23.09. | COVID : Brasile, Bolsonaro in quarantena dopo positività min.Salute | |
| 23.09. | ASTRAZENECA : Takes Stake In UK's VaxEquity Under Long-Term Partnership | |
| 23.09. | ASTRAZENECA : invests in Imperial's self-amplifying RNA technology with eye on future drug.. | |
| 23.09. | ASTRAZENECA : to discover and develop self-amplifying RNA therapeutics in new collaboratio.. | |
| 23.09. | AstraZeneca PLC Appoints Diana Layfield as Member of the Science Committee, with Effect.. | |
| 23.09. | AstraZeneca PLC Announces Board Appointments | |
| 23.09. | VaxEquity Announces Strategic Collaboration with AstraZeneca to Commercialise Self-Ampl.. | |
| 23.09. | ASTRAZENECA : Japan doubles COVID-19 vaccine donation pledge to 60 mln doses | |
| 23.09. | ASTRAZENECA : Brazil regulator says adolescent death unrelated to Pfizer shot | |
| 23.09. | VaxEquity announced that it has received funding from AstraZeneca PLC, Morningside Vent.. | |
| 22.09. | MODERNA : Canada paused COVID-19 vaccine deliveries as supply far exceeds demand | |
| 22.09. | ASTRAZENECA : Anger, confusion spread over UK's new COVID travel rules | |
| 22.09. | PFIZER : COVID-19 Vaccine Elicits Strong Immune Response As Second Dose, Thailand Study Sa.. | |
| 22.09. | SINOVAC BIOTECH : Thailand delays plan to re-open cities to tourists until November | |
| 22.09. | India's Serum Institute to invest $68 mln in UK vaccine maker Oxford Biomedica | |
| 22.09. | ASTRAZENECA : MEDIA-UK govt approves Covishield as qualified vaccine for travel - Mint | |
| 22.09. | OXFORD BIOMEDICA : Swings to H1 Profit on Revenue from COVID-19 Vaccine Manufacturing | |
| 22.09. | ASTRAZENECA : India likely to allow smaller gap between AstraZeneca COVID vaccine doses so.. | |
| 21.09. | INDIA NO COMPRARÁ VACUNAS COVID-19 D : fuentes | |
English (USA)
English (UK)
English (Canada)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Bericht
